RxSIGHT, INC. (RXST) stock plummeted 6.06% on Wednesday, likely due to a series of analyst rating and price target adjustments.

BTIG lowered its price target on RXST from $58 to $44, although it maintained a Buy rating. The firm's decision to lower the price target could have contributed to the stock's decline, as it reflects a more conservative valuation outlook.

Meanwhile, Stifel Nicolaus maintained a Hold rating on RXST and set a price target of $33, while Needham reiterated its $43 price target on the stock. These neutral-to-negative analyst actions may have weighed on investor sentiment, leading to the selloff in RXST shares.